WuXi Apptec WKN: A2PAJG ISIN: CNE100003F19 Forum: Aktien User: Summer.76

https://m.jrj.com.cn/madapter/hk/2022/02/15185534354811.shtml

https://m.jrj.com.cn/madapter/hk/2022/03/10151834808721.shtml

https://www.prnewswire.com/news-releases/wuxi-apptec-reports-strong-revenue-growth-in-2021-301508858.html

"WuXi AppTec plant den Aufbau eines neuen Standorts in Singapur, um globale Partner besser zu bedienen und Innovationen im Gesundheitswesen voranzutreiben" https://www.prnewswire.com/news-releases/wuxi-apptec-plans-to-build-a-new-site-in-singapore-better-serving-global-partners-and-advancing-healthcare-innovation-301588964.html

"WuXi AppTec Reports Record First-Half Results in 2022" https://www.prnewswire.com/news-releases/wuxi-apptec-reports-record-first-half-results-in-2022-301593151.html

WuXi AppTec expects to make more profit last year and increase by 70% https://inews.hket.com/article/3158693/%E3%80%90%E7%9B%88%E5%96%9C%EF%BD%9CCRO%E3%80%91%E8%97%A5%E6%98%8E%E5%BA%B7%E5%BE%B7%E6%96%99%E5%8E%BB%E5%B9%B4%E5%A4%9A%E8%B3%BA%E5%A2%9E7%E6%88%90%E3%80%80%E8%82%A1%E5%83%B9%E9%AB%98%E9%96%8B%E5%80%92%E8%B7%8C7-%E3%80%81%E6%91%A9%E9%80%9A%E4%B8%8A%E8%AA%BF%E7%9B%AE%E6%A8%99%E5%83%B9?mtc=20038

WuXi AppTec has stopped falling and turbulence, and biomedicine is still a popular track https://m.cn.investing.com/analysis/article-200469449

https://finance.sina.cn/hkstock/ggyw/2021-12-16/detail-ikyamrmy9275471.d.html?from=wap

Der CRO-Sektor beschleunigte seinen Rückgang am Nachmittag... https://finance.sina.cn/hkstock/ggyw/2021-12-15/detail-ikyakumx4292300.d.html?from=wap

https://www.biospectrumasia.com/news/40/19433/chinas-wuxi-sta-forms-strategic-partnership-with-coherent-biopharma.html

WuXi ATU Opens New Facility in Philadelphia, Tripling Testing Capacity to Support Global Customers https://www.prnewswire.com/news-releases/wuxi-atu-opens-new-facility-in-philadelphia-tripling-testing-capacity-to-support-global-customers-301423668.html New state-of-the-art advanced therapies testing laboratories provide additional capacity for the growing cell and gene therapy industry.

WuXi AppTec Reports Strong Third-Quarter 2021 Results https://www.wfmz.com/news/pr_newswire/pr_newswire_health/wuxi-apptec-reports-strong-third-quarter-2021-results/article_85e75845-d42f-50af-92e1-bd9c2ba6c87e.html

Chinese fund managers buy new-energy stocks and ditch tech giants, quarterly portfolio report shows https://www.scmp.com/business/markets/article/3154027/chinese-fund-managers-buy-new-energy-stocks-and-ditch-tech-giants • Sungrow Power Supply, WuXi AppTec and Shanxi Xinghuacun saw the biggest increases in holdings of fund managers in the third quarter • Total assets managed by China’s mutual funds increased 4 per cent quarter on quarter to US$3.7 trillion at the end of September ...

Fitch Upgrades WuXi AppTec's IDR to 'BBB'; Outlook Stable https://www.fitchratings.com/research/corporate-finance/fitch-upgrades-wuxi-apptec-idr-to-bbb-outlook-stable-25-10-2021

Lässt sich auch ohne die App lesen: Pharmaceutical stocks pay attention to growth confirmation  https://specialist.hket.com/article/3086579/%E3%80%90%E8%B4%8F%E9%9D%A2%E8%82%A1%E8%BF%BD%E8%B9%A4%E3%80%91%20%E9%86%AB%E8%97%A5%E8%82%A1%E7%95%99%E6%84%8F%20%20%20%E6%88%90%E9%95%B7%E6%80%A7%E7%A2%BA%E5%AE%9A%20%20%EF%BC%88%E9%99%84%E8%82%A1%E7%A5%A8%E6%8E%A8%E4%BB%8B%EF%BC%89%EF%BC%88%E7%AC%AC%E4%BA%8C%E7%89%88%EF%BC%89 In the medium term, the growth determined by the pharmaceutical sector will still be one of the main directions for investment in the entire market in 2022. October and even Q4 will be the best time to deploy the pharmaceutical sector. This research report will focus on the investment strategy of the pharmaceutical industry and recommend favorite stocks, such as WuXi AppTec (02359) , Cinda Bio (01801) , Ascent Pharmaceuticals (06855) and Rongchang Bio (09995), etc. It is also recommended to pay attention WuXi Biologics (02269) , Tigermed (03347), etc. The main reasons for the obvious signs of stabilization in the pharmaceutical sector: ...